Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
Abstract Background Patients with cancer history are usually excluded from hepatocellular carcinoma (HCC) clinical trials. However, whether previous malignancy affects the oncological outcomes of HCC patients has not been fully assessed. This study aimed to evaluate whether prior cancer compromised...
Main Authors: | Xuqi Sun, Lingling Li, Li Xu, Zhongguo Zhou, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Dandan Hu, Minshan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-07870-0 |
Similar Items
-
Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
by: Muneer J. Al-Husseini, et al.
Published: (2019-08-01) -
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
by: Xuqi Sun, et al.
Published: (2021-07-01) -
Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
by: Jinbin Chen, et al.
Published: (2018-10-01) -
The guiding value of microvascular invasion for treating early recurrent small hepatocellular carcinoma
by: Xuqi Sun, et al.
Published: (2021-01-01) -
The effect of prior cancer on non‐small cell lung cancer trial eligibility
by: Michael Herman, et al.
Published: (2021-07-01)